View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB36 | Publication ID: Spring 2015 |
Title: Amendments to the Drug Enforcement Administration Hearing Regulations | |
Abstract:
This rule proposes to amend the Drug Enforcement Administration (DEA) hearing regulations. In this rule the DEA proposes to amend its regulations that govern the procedures in administrative hearings to deny, revoke or suspend a DEA registration to handle controlled substances or listed chemicals. These regulations have not been amended since the inception of the regulations in 1971. |
|
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 21 CFR 1316 | |
Legal Authority: 21 U.S.C. 811 21 U.S.C. 812 21 U.S.C. 871(b) 21 U.S.C. 875 21 U.S.C. 958(d) 21 U.S.C. 965 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Demetra Ashley Associate Deputy Assistant Administrator Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7165 |